![Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods | Protocol (Translated to German) Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/60335/60335fig04.jpg)
Simultaneous Flow Cytometric Characterization of Multiple Cell Types Retrieved from Mouse Brain/Spinal Cord Through Different Homogenization Methods | Protocol (Translated to German)
![EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents](https://patentimages.storage.googleapis.com/7d/34/d2/42f77fd0c0785b/00240001.png)
EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents
![Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German) Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/10494/10494fig2.jpg)
Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)
![Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German) Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/55445/55445fig3.jpg)
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)
![Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German) Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/10494/10494table1.jpg)
Flow Cytometry and Fluorescence-Activated Cell Sorting (FACS): Isolation of Splenic B Lymphocytes | Protocol (Translated to German)
![Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German) Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/55445/55445fig2.jpg)
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)
![Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German) Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)](https://cloudfront.jove.com/files/ftp_upload/55445/55445fig1.jpg)
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation | Protocol (Translated to German)
![EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents](https://patentimages.storage.googleapis.com/3d/20/49/969644366db844/00250001.png)
EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents
![EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents](https://patentimages.storage.googleapis.com/71/0a/71/ea2b1f367990a8/00260001.png)
EP1600460A1 - Use of an active substance that binds to CD28 for producing a pharmaceutical composition for treatment of B-CLL - Google Patents
![iNOS Rat anti-Mouse, PE, Clone: CXNFT, eBioscience™ 25 μg; PE iNOS Rat anti-Mouse, PE, Clone: CXNFT, eBioscience™ | Fisher Scientific iNOS Rat anti-Mouse, PE, Clone: CXNFT, eBioscience™ 25 μg; PE iNOS Rat anti-Mouse, PE, Clone: CXNFT, eBioscience™ | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/figures/12-5920-82_iNOS_Flow_1-20170119083539.jpg-650.jpg)